|
[1]
|
Zhao, L.F. and Fu, Z.Y. (2018) Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy. Journal of Immunology Research, 2018, Article ID: 5301548. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Sznol, M., Postow, M.A., Davies, M.J., et al. (2017) Endocrine-Related Adverse Events Associated with Immune Checkpoint Blockade and Expert Insights on Their Management. Cancer Treatment Reviews, 58, 70-76. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Hassel, J.C., Heinzerling, L., Aberle, J., et al. (2017) Combined Immune Checkpoint Blockade (Anti-PD-1/Anti-CTLA-4): Evaluation and Management of Adverse Drug Reactions. Cancer Treatment Reviews, 57, 36-49. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Esfahani, K., Buhlaiga, N., Thébault, P., Lapointe, R., Johnson, N.A. and Miller Jr., W.H. (2019) Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy. The New Eng-land Journal of Medicine, 380, 2375-2376. [Google Scholar] [CrossRef]
|
|
[5]
|
Wang, Y., Zhou, S., Yang, F., et al. (2019) Treatment-Related Ad-verse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis. JAMA Oncology, 5, 1008-1019. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Brumbaugh, A.D., Narurkar, R., Parikh, K., Fanucchi, M. and Frishman, W.H. (2019) Cardiac Immune-Related Adverse Events in Immune Checkpoint Inhibition Therapy. Cardiology in Review, 27, 97-107. [Google Scholar] [CrossRef]
|
|
[7]
|
Weinmann, S.C. and Pisetsky, D.S. (2019) Mechanisms of Immune-Related Adverse Events during the Treatment of Cancer with Immune Checkpoint Inhibitors. Rheumatology, 58, vii59-vii67. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Varricchi, G., Galdiero, M.R., Marone, G., et al. (2017) Cardio-toxicity of Immune Checkpoint Inhibitors. ESMO Open, 2, e000247. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Moslehi, J.J., et al. (2018) Increased Reporting of Fatal Im-mune Checkpoint Inhibitor-Associated Myocarditis. The Lancet, 391, 933. [Google Scholar] [CrossRef]
|
|
[10]
|
Mahmood, S.S., Fradley, M.G., Cohen, J.V., et al. (2018) Myocarditis in Patients Treated with Immune Checkpoint Inhibitors. Journal of the American College of Cardiology, 71, 1755-1764. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wang, P.F., Chen, Y., Song, S.Y., et al. (2017) Im-mune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis. Fron-tiers in Pharmacology, 8, 730. [Google Scholar] [CrossRef] [PubMed]
|